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 Abstract 
 Background:  Different measures of body fat composition may vary in their relations to pa-
rameters of chronic inflammation.  Methods:  We assessed the relations of visceral (VAT) and 
subcutaneous adipose tissue (SAT), BMI, and waist circumference (WC) to serum concentra-
tions of high-sensitive C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), inter-
leukin-6 (IL-6), resistin, and adiponectin in 97 healthy adults using multivariate linear regres-
sion models, adjusted for age, sex, smoking, physical activity, menopausal status, and use of 
aspirin or non-steroidal anti-inflammatory drugs (NSAIDs). Parameters of chronic inflamma-
tion were mutually adjusted.  Results:  VAT (β = 0.34), SAT (β = 0.43), BMI (β = 0.40), and WC 
(β = 0.47) were all significantly associated with hs-CRP. BMI was additionally inversely related 
to adiponectin (β = –0.29). In exploratory subgroup analyses defined by gender, BMI, smok-
ing, and use of aspirin or NSAIDs, VAT was the strongest indicator for increased levels of IL-6, 
SAT was the most consistent indicator for increased levels of hs-CRP, and BMI was the most 
consistent indicator for decreased levels of adiponectin. WC showed to be a weak indicator 
for increased levels of hs-CRP and decreased levels of adiponectin.  Conclusion:  VAT, SAT, BMI, 
and WC show distinct associations with parameters of chronic inflammation. Whether these 
differences reflect differential metabolic risks requires clarification by longitudinal studies. 
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 Introduction  
 Obesity is a major public health problem, the prevalence of which has doubled since 1980 
in the developed and in many developing parts of the world  [1] . Obesity is a strong predictor 
of diabetes mellitus, hypertension, stroke, and several types of cancer  [2–4] . What drives the 
association between obesity and metabolic diseases remains unclear. Visceral adipose tissue 
(VAT) has been considered to have multiple endocrine, metabolic, and immunological func-
tions and may be more strongly associated with cardiometabolic risk factors than subcuta-
neous adipose tissue (SAT)  [5–9] . However, data examining potential differences between 
VAT and SAT with regard to cardiometabolic risk factors are not entirely consistent  [10] . 
 In obesity, adipocytes are enlarged, and their secretory properties are altered  [11] . 
Specifically serum levels of tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and 
high-sensitive C-reactive protein (hs-CRP) are increased, while adiponectin is decreased  [12] . 
Whether obesity is related to resistin is unclear  [13–17] . Systemic inflammation plays a major 
role in all stages of atherosclerosis, from initiation over progression to rupture of atheroscle-
rotic plaques  [18] . Moreover, increased circulating levels of hs-CRP, IL-6, and TNF-α are asso-
ciated with worse cardiovascular outcomes  [19, 20] .
 Previous studies examining the associations between obesity and inflammatory cyto-
kines used BMI, waist circumference (WC) or waist-to-hip ratio (WHR) as underlying measure 
of adiposity  [16, 17, 21–31] . Because those measures do not differentiate between VAT and 
SAT, they were unable to fully characterize body fat distribution patterns. Of the studies that 
did consider body fat distribution, most focused on VAT  [24, 26, 32–38] , but less is known 
about the associations between SAT and parameters of systemic chronic inflammation. 
Specifically the relation between SAT and hs-CRP has been studied to some extent  [24, 32–35, 
37–39] , whereas the associations between SAT and IL-6, TNF-α  [33, 34, 37, 38, 40] , resistin 
 [41, 42] , or adiponectin  [35, 40, 43, 44] have not been targeted sufficiently. In addition, results 
are inconsistent, and only few studies that examined the relation between VAT or SAT and 
inflammatory parameters  [33, 38, 43] reported results from multivariate analyses. Moreover, 
no study has compared different measures of obesity with regard to their relations to param-
eters of chronic inflammation. Thus, we sought to examine the relations of VAT, SAT, BMI, and 
WC to selected parameters of systemic chronic inflammation in healthy adults.
 Material and Methods 
 Study Design and Population  
 A cross-sectional study was conducted in Germany between June and August 2011. A total of 97 partic-
ipants (55 women, 42 men) aged 22–69 years were randomly selected through the local population registry. 
The study was conducted according to the Declaration of Helsinki guidelines and approved by the local ethics 
committee. Written informed consent was obtained from all participants.
 Anthropometric Measurements 
 VAT and SAT were quantified using a B-mode ultrasound machine (Mindray DP-50; Mindray Medical 
Germany GmbH, Darmstadt, Germany) and a 3.5–5.0 MHz convex array transducer. Measurements were 
performed according to a strict protocol, details of which are described elsewhere  [45] . Briefly, the method 
involved multiple image planes that provided information on adipose tissue thickness. The SAT measurement 
involved one individual image plane at the median line extending from the skin to the linea alba. VAT was 
measured using a second image plane reaching from the linea alba to the lumbar vertebra corpus at the 
median line. All measurements were performed manually by the same examiner at the end of normal expi-
ration applying minimal pressure without displacement of the intra-abdominal contents as verified by the 
ultrasound image. The parameters from the images were manually extracted using the electronic onboard 
caliper and were stored directly in a database. Height and weight were measured with participants wearing 
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underwear without shoes. BMI was calculated by dividing body weight (kg) by height in meters squared (m²). 
Waist circumference was measured at the mid-point between the lower rib and the iliac crest. Measurements 
were taken with the participant standing in an upright position.
 Serum Analysis 
 Non-fasting venous blood was drawn by qualified medical staff. Blood was immediately fractionated 
into serum, plasma, buffy coat, and erythrocytes and aliquoted into straws of 0.5 ml each according to a stan-
dardized protocol. During blood withdrawal and processing, time and room temperature were steadily docu-
mented. The straws were stored in conventional tubes at –80 °  C. Serum concentrations of TNF-α, IL-6, 
resistin, and adiponectin were measured using an enzyme-linked immunosorbent assay (Immundiagnostik, 
Bensheim, Germany), and hs-CRP was determined by immunonephelometry (Behring Nephelometer II, Dade 
Behring, Marburg, Germany). 
 Covariate Assessment 
 Potential confounding variables including age, sex, current smoking status, physical activity, use of 
aspirin or non-steroidal anti-inflammatory drugs (NSAIDs), and menopausal status in women were assessed 
by standardized computer-assisted personal interviews specifically developed for the study. Smoking status 
was categorized as currently smoking or non-smoking. Physical activity levels were calculated from meta-
bolic equivalents of task (METs) by a 24-hour physical activity recall. Drug use during the previous 7 days 
was documented by pharmaceutical control numbers using codes of the anatomical therapeutic chemical 
classification system.
 Statistical Analysis 
 Descriptive statistics were calculated using direct standardization according to the age distribution of 
the study population and stratified by VAT and SAT tertiles. The data regarding hs-CRP, TNF-α, IL-6, resistin, 
and adiponectin were not distributed normally and were therefore log transformed for further analyses. We 
calculated Pearson correlations between measures of obesity and between selected parameters of systemic 
chronic inflammation. In addition, we calculated partial correlation coefficients between inflammatory 
parameters adjusted for age, sex, current smoking status, physical activity, menopausal status, and use of 
aspirin or NSAIDs. 
 Multivariate linear regression analysis was performed to estimate relations of VAT, SAT, BMI, and WC 
to hs-CRP, IL-6, TNF-α, resistin, and adiponectin, adjusted for age (continuous), sex (men; women), smoking 
status (currently smoking; non-smoking), physical activity (continuous), menopausal status (pre-, peri-, or 
postmenopausal), and aspirin or NSAID use (drug use during the past 7 days: yes; no). In a second model, all 
parameters of chronic inflammation were mutually adjusted in addition to the adjustments described in the 
first model. In a third model, VAT and SAT were mutually adjusted, and BMI and WC were mutually adjusted. 
We also ran exploratory analyses stratified by sex, BMI, smoking status, and aspirin or NSAID use. Before 
fitting the linear regression models, all variables (independent and dependent) were standardized by 
subtracting the mean and dividing by the standard deviation to make relations comparable. When reporting 
the results from the linear regression models, β-coefficients were considered weak (β  ≤ 0.3), moderate (β > 
0.3 to  ≤ 0.6), or strong (β > 0.6). All reported p values are two-tailed, and values < 0.05 were deemed statis-
tically significant. IBM SPSS statistics 22 (Chicago, IL, USA) was used for all analyses.
 Results 
 Subject Characteristics 
 Characteristics of the study population are presented in  table 1 . The mean age of study 
participants was 53.5 years. Participants in the upper VAT tertile ( ≥ 8.07 cm) tended to be 
older, to be of male gender, to have higher levels of BMI and WC, and to be more likely to 
report using aspirin or NSAIDs than those in the lower VAT tertile ( ≤ 5.66 cm). In contrast, 
study subjects with high VAT were less likely to currently smoke than those with low VAT. 
There were no appreciable differences in physical activity levels according to VAT. Partici-
pants in the upper SAT tertile ( ≥ 2.15 cm) were more likely to be of female gender, to have 
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higher levels of BMI and WC, and to be less likely to currently smoke than those in the inter-
mediate (1.63 to  ≤ 2.14 cm) or lower SAT tertile ( ≤ 1.62 cm). There were no appreciable differ-
ences in physical activity levels according to SAT. The mean concentrations of selected param-
eters of chronic inflammation were generally higher in men compared to women, with the 
exception of adiponectin, which was higher in women than in men ( table 2 ). 
 VAT was significantly positively correlated with SAT (r = 0.37; p < 0.0001), BMI (r = 0.83; 
p < 0.0001), and WC (r = 0.79; p < 0.0001). As compared to VAT, SAT showed weaker correla-
tions with BMI (r = 0.59; p < 0.0001) and WC (r = 0.51; p < 0.0001). BMI and WC were highly 
correlated with each other (r = 0.85; p < 0.0001) (data not tabulated).
 Hs-CRP was significantly positively correlated with TNF-α (r = 0.21; p = 0.04) but was not 
significantly correlated with IL-6, resistin, or adiponectin ( table 3 ). After adjustment for age, 
sex, smoking, physical activity, menopausal status and aspirin or NSAID use, the only statisti-
cally significant partial correlation was that between adiponectin and TNF-α (r = 0.31; p = 
0.02).
 Initial multiple linear regression analyses unadjusted for parameters of systemic chronic 
inflammation showed that VAT was weakly positively associated with hs-CRP (β = 0.12; p = 
0.004), moderately positively with IL-6 (β = 0.33; p = 0.002) and weakly inversely associated 
with adiponectin (β = –0.20; p = 0.048) ( table 4 ). No relations of VAT to TNF-α or resistin were 
 Table 1.  Age-standardized characteristics of participants according to tertiles of VAT and SATa
Charact eristic VAT  SAT 
tertile 1
(≤5.66 cm)
tertile 2
(5.67 to ≤8.06 cm)
tertile 3
(≥8.07cm)
tertil e 1
(≤1.62 cm)
tertile 2
(1.63 to ≤2.14 cm)
tertile 3
(≥2.15 cm)
Number of participants 32 33 32 32 33 32
Age, years 48 55 58 49 59 52
Sex, % men 29 46 59 47 44 35
BMI, kg/m² 23.5 26.1 31.6 24.0 27.6 29.4
WC, cm 80.9 90.1 105 84.1 92.6 97.6
Smoking, % 24 19 19 24 23 14
Physical activity level 1.7 1.7 1.7 1.7 1.8 1.7
Use of aspirin or NSAIDs, % 5 21 21 11 19 16
 aContinuous variables values are expressed as mean values and categorical variables are expressed as proportions. 
 Table 2.  Markers of systemic chronic inflammation by gender (women: n = 55; men: n = 42)
Women Men Total
Age, years 55.55 ± 10.18 50.81 ± 14.52 53.49 ± 12.41
VAT, cm 6.79 ± 3.22 8.39 ± 3.64 7.48 ± 3.48
SAT, cm 2.05 ± 0.77 1.89 ± 0.89 1.98 ± 0.82
BMI, kg/m² 26.46 ± 4.91 27.57 ± 4.39 26.94 ± 4.68
WC, cm 86.60 ± 12.30 97.83 ±13.30 91.51 ± 13.86
hs-CRP, mg/dl 0.15 ± 0.12 0.20 ± 0.26 0.17 ± 0.19
TNF-α, pg/ml 6.18 ± 2.10 6.89 ± 2.53 6.49 ± 2.31
IL-6, pg/ml 2.42 ± 2.48 3.00 ± 4.97 2.67 ± 3.76
Resistin, ng/ml 3.49 ± 1.16 3.65 ± 1.07 3.56 ± 1.12
Adiponectin, μg/ml 14.04 ± 5.25 9.34 ± 4.04 12.00 ± 5.28
 Results are expressed as mean value ± SD.
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found. SAT was moderately positively associated with hs-CRP (β = 0.60; p = 0.0005), but it 
was unrelated to any of the other parameters. BMI showed a moderate positive association 
with hs-CRP (β = 0.39; p = 0.004) and a weak positive association with IL-6 (β = 0.22; p = 
0.034). A moderate inverse association was found between BMI and adiponectin (β = –0.32; 
p = 0.002). No relations of BMI were found to TNF-α or resistin. WC was moderately positively 
 Table 3.  Correlation matrix with selected parameters of systemic chronic inflammation
Log hs-CRP Log TNF-α Log IL-6 Log resistin
Log hs-CRP1 1
Log hs-CRP2 1
Log TNF-α1 r = 0.21, p = 0.04 1
Log TNF-α2 r = 0.18, p = 0.15 1
Log IL-61 r = 0.16, p = 0.11 r = 0.10, p = 0.34 1
Log IL-62 r = 0.11, p = 0.42 r = –0.07, p = 0.58 1
Log resistin1 r = 0.10, p = 0.30 r = 0.09, p = 0.37 r = –0.01, p = 0.90 1
Log resistin2 r = 0.09, p = 0.52 r = -0.01, p = 0.97 r = 0.03, p = 0.84 1
Log adiponectin1 r = –0.14, p = 0.16 r = 0.06, p = 0.53 r = –0.00, p = 0.97 r = 0.06, p = 0.56
Log adiponectin2 r = –0.11, p = 0.41 r = 0.31, p = 0.02 r = 0.02, p = 0.89 r = 0.08, p = 0.53
 1Pearson correlation between parameters of systemic chronic inflammation. 
2Pearson correlation between parameters of systemic chronic inflammation adjusted for age, physical 
activity level, sex, menopausal status (women only) smoking, and aspirin or NSAID use.
 Table 4.  Relations of VAT, SAT, BMI, and WC to selected parameters of systemic chronic inflammation
VAT SAT BMI  WC
β p β p β p β p
Log hs-CRP1 0.12 0.004 0.60 0.0005 0.39 0.004 0.46 0.001
Log hs-CRP2 0.33 0.02 0.42 0.001 0.36 0.013 0.41 0.006
Log hs-CRP³ 0.17 0.25 0.35 0.01 0.05 0.88 0.36 0.26
Log TNF-α1 0.14 0.31 –0.07 0.61 0.01 0.94 0.08 0.61
Log TNF-α2 0.16 0.27 –0.11 0.44 0.05 0.73 0.07 0.69
Log TNF-α³ 0.22 0.15 –0.19 0.22 –0.05 0.88 0.11 0.76
Log IL-61 0.33 0.002 0.13 0.22 0.22 0.03 0.14 0.32
Log IL-62 0.22 0.12 0.17 0.23 0.11 0.44 0.13 0.42
Log IL-6³ 0.18 0.24 0.10 0.50 0.03 0.92 0.10 0.77
Log resistin1 –0.09 0.49 0.15 0.26 –0.05 0.73 –0.05 0.74
Log resistin2 –0.14 0.38 0.15 0.33 –0.07 0.66 –0.09 0.62
Log resistin³ –0.22 0.20 0.22 0.18 0.04 0.91 –0.13 0.74
Log adiponectin1 –0.20 0.048 –0.15 0.12 –0.32 0.002 –0.28 0.012
Log adiponectin2 –0.19 0.17 –0.12 0.37 –0.28 0.035 –0.18 0.24
Log adiponectin³ –0.16 0.26 –0.06 0.68 –0.58 0.035 0.39 0.19
 1Models are adjusted for age, physical activity level, sex, smoking, menopausal status (women only), 
and aspirin or NSAID use. 
2Models are adjusted for age, physical activity level, sex, smoking, menopausal status (women only), 
aspirin or NSAID use, and mutually adjusted for all parameters of systemic chronic inflammation. 
3Models are adjusted for age, physical activity level, sex, smoking, menopausal status (women only), 
aspirin or NSAID use, and mutually adjusted for all parameters of systemic chronic inflammation. In 
addition, VAT and SAT are mutually adjusted and BMI and WC were mutually adjusted.
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associated with hs-CRP (β = 0.46; p = 0.001) and moderately inversely associated with adipo-
nectin (β = –0.28; p = 0.012). 
 After mutual adjustment of parameters of systemic chronic inflammation, VAT remained 
significantly associated with hs-CRP but not with IL-6 or adiponectin ( table 4 ). SAT remained 
significantly associated with hs-CRP, and BMI remained significantly associated with hs-CRP 
and adiponectin. WC remained significantly associated with hs-CRP. When VAT and SAT were 
simultaneously included in the model, only SAT remained significantly associated with 
hs-CRP. After mutual adjustment of BMI and WC, BMI remained significantly inversely related 
to adiponectin.
 We next conducted an analysis stratified by gender ( table 5 ). In women, we noted a 
moderate inverse association between BMI and adiponectin (β = –0.42; p = 0.045). In men, 
we observed moderate positive relations of VAT and BMI to IL-6 (β = 0.47; p = 0.01 and β = 
0.36; p = 0.049, respectively). No statistically significant relations were found between VAT, 
SAT, BMI, or WC and other inflammatory parameters in men or women, although we noted 
gender differences for all inflammatory parameters. With the exception of SAT, relations of 
VAT, BMI, and WC to hs-CRP appeared to be stronger in women than in men. Inverse relations 
of VAT, SAT, BMI and WC to TNF-α and to IL-6 were found in women, whereas in men only 
SAT was inversely related to TNF-α. Relations of VAT, SAT, BMI and WC to IL-6 were stronger 
in men than in women.
 In non-obese participants, no statistically significant relations were found of VAT, SAT, 
BMI, or WC to any of the inflammatory parameters ( table 5 ). In overweight/obese partici-
pants, VAT showed a moderate association with IL-6 (β = 0.39; p = 0.03), and SAT was statis-
tically significantly associated with hs-CRP (β = 0.33; p = 0.04). BMI and WC showed moderate 
inverse associations with adiponectin (β = –0.47; p = 0.02 and β = –0.46; p = 0.01, respec-
tively). In general, VAT and BMI showed stronger relations to inflammatory parameters in 
overweight/obese participants than in normal-weight participants, whereas associations 
between SAT and inflammatory parameters were stronger in normal-weight than in over-
weight/obese participants. 
 In an analysis restricted to current non-smokers, VAT was positively associated with IL-6 
(β = 0.36; p = 0.01), and SAT showed a moderate significant association with hs-CRP (β = 0.35; 
p = 0.01) ( table 5 ). BMI was positively associated with IL-6 (β = 0.29; p = 0.048) and it showed 
an inverse association with adiponectin (β = –0.34; p = 0.01). WC also showed an inverse asso-
ciation with adiponectin (β = –0.27; p = 0.049). By comparison, in an analysis restricted to 
current smokers, VAT, BMI, and WC showed strong positive associations with hs-CRP (β = 
0.74; p = 0.001, β = 0.80; p = 0.00003, and β = 0.88; p = 0.0003, respectively), and a moderate 
positive association was found between SAT and hs-CRP (β = 0.49; p = 0.049). Associations 
between VAT and inflammatory markers were stronger in current smokers than in non-
smokers. 
 In an analysis limited to non-users of aspirin or NSAIDs, VAT showed moderate positive 
associations with IL-6 (β = 0.29; p = 0.046) and TNF-α (β = 0.30; p = 0.049) ( table 5 ). SAT, BMI, 
and WC showed moderate positive associations with hs-CRP (β = 0.41; p = 0.01, β = 0.31; p = 
0.04, and β = 0.31; p = 0.04, respectively). Also, BMI showed a weak inverse association with 
adiponectin (β = –0.30; p = 0.04). In an analysis restricted to participants using aspirin and 
NSAIDs, VAT showed a moderate positive association with hs-CRP (β = 0.57; p = 0.04). WC 
showed a strong positive association with hs-CRP (β = 0.72; p = 0.03) and a strong inverse 
association with adiponectin (β = –0.89; p = 0.001). In general, VAT, SAT, BMI, and WC were 
inversely related to TNF-α and IL-6 in users of aspirin or NSAIDs, whereas VAT, BMI, and WC 
were positively related to these parameters in non-users of aspirin and NSAIDs.
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 Discussion 
 In this population-based study of healthy adults, VAT, SAT, BMI, and WC showed distinct 
associations with selected parameters of chronic inflammation. Specifically VAT, SAT, BMI, 
and WC demonstrated a positive relation to hs-CRP. However, the strongest relation was 
found between SAT and hs-CRP. Compared to the other anthropometric variables, BMI 
showed a stronger inverse association with adiponectin. Albeit not significant, VAT was the 
strongest indicator for increased levels of IL-6 and TNF-α. WC was only weakly related to 
inflammatory parameters. These findings were fairly consistent throughout subgroups 
defined by gender, BMI, current smoking, and use of aspirin and NSAIDs. 
 Similar to our results, previous studies among healthy adults reported that VAT, SAT, 
BMI, or WC were positively associated with CRP  [24, 32–34, 38, 46] . Several investigations 
reported comparable relations of VAT and SAT to CRP  [33, 38] or a stronger association with 
VAT  [32, 34, 37] , whereas other studies found a stronger relation to SAT  [35, 38, 46] . However, 
none of the aforementioned studies mutually adjusted their analyses for inflammatory param-
eters or for VAT and SAT  [32–35, 37, 38, 46] . When VAT and SAT were mutually adjusted, we 
found that only SAT remained significantly associated with hs-CRP, indicating that abdominal 
SAT may have a pathogenic function, as additionally evidenced by endocrine and inflam-
matory responses  [5, 10, 12, 47] . 
 That relations of VAT, BMI, and WC to hs-CRP were stronger in women than in men 
agrees with previous studies  [21, 22, 33, 38] and may be due to enhanced estrogen production 
in the adipose tissue with upregulation of pro-inflammatory gene expression in women  [48, 
49] . Our findings in women of similar relations of VAT, SAT, BMI, and WC to hs-CRP suggest 
that in women associations with CRP are more strongly determined by overall fat mass than 
by fat distribution. In contrast, in men we noted that SAT, but not VAT, BMI, or WC, was most 
strongly associated with CRP, which is consistent with previous studies  [35, 38, 46] and indi-
cates that adiposity relations with CRP in men may be less strongly influenced by overall fat 
mass.
 Our observation of a more pronounced relation of SAT than of VAT to hs-CRP in over-
weight/obese subjects has not yet been reported. Only one previous study stratified the 
examination by BMI and found no significant association between SAT and CRP in obese 
subjects  [37] . In contrast to that study, we considered potential confounding variables in 
multivariate analyses. In obese individuals, the limited ability of abdominal SAT to store 
excess energy may cause an increase in free fatty acids (FFA) flux to the portal vein and the 
systemic circulation  [9] . Elevated FFA levels are related to increased CRP  [50] . 
 All anthropometric variables showed stronger associations with hs-CRP in current 
smokers than in non-smokers. Cigarette smoking is associated with increased CRP levels  [51] , 
which may partly reflect the mechanisms believed to underlie the adverse effects of smoking 
on cardiovascular disease and several types of cancer  [52] . None of the previous studies that 
examined the relation between adiposity and CRP reported results stratified by smoking 
status  [24, 32–34, 38, 46] . Also, previous studies examining the relations of obesity to CRP 
and other inflammatory parameters did not report findings stratified by aspirin or NSAIDs 
use  [24, 32–34, 38, 46] . We found that associations of anthropometric factors to hs-CRP were 
more pronounced among users of aspirin or NSAIDs. Because NSAIDs down-regulate inflam-
matory cytokine production including CRP  [53, 54] , we would have expected to observe less 
pronounced associations with inflammatory parameters among users than among non-users 
of aspirin or NSAIDs. 
 Our findings from multivariate analyses without mutual adjustments for inflammatory 
parameters or for VAT and SAT are consistent with those from previous studies reporting a 
positive association between VAT and IL-6  [33, 34, 37, 38, 40] and no relation between SAT 
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and IL-6  [37, 38, 40] . However, the positive relation of VAT to IL-6 was rendered non-signif-
icant after mutual adjustment for other parameters of systemic chronic inflammation and 
when SAT was included in the model. Significantly positive associations between VAT and 
IL-6 emerged in additional analyses among men, overweight/obese, current non-smokers, 
and participants not using aspirin and NSAIDs. In these analyses, we additionally found that 
associations between VAT and IL-6 were stronger than those between BMI and IL-6, indi-
cating that collecting data on VAT may represent metabolic information captured by IL-6 that 
is not accounted for by BMI. Only one previous study stratified its population by gender and 
reported a stronger relation between VAT and IL-6 in women than in men  [38] . However, that 
study was limited to elderly individuals, which may explain the difference from our finding. 
Men have larger visceral fat depots than women  [55, 56], and IL-6 is predominantly expressed 
and secreted by VAT  [57] . 
 We found no overall relations of VAT, SAT, BMI, or WC to TNF-α, which is similar to other 
studies that addressed these associations  [33, 34, 37] . Albeit not significant, we found a 
stronger relation of VAT to TNF-α compared to the relations of other obesity measures to 
TNF-α. In further exploratory analyses, we noted significantly positive relations of VAT to 
TNF-α and IL-6 among non-users of aspirin or NSAIDs, which may be due to NSAID-mediated 
down-regulation of inflammatory cytokine production  [53, 54] . The available literature 
includes one study that reported a positive relation between VAT and TNF-α in adults aged 
70 to 79 years, but no association between SAT and TNF-α  [38] , and another study that found 
positive relations of both VAT and SAT to TNF-α among obese adolescents  [40] . However, 
none of these studies mutually adjusted their analyses for inflammatory parameters or for 
VAT and SAT.
 We were unable to detect any associations between adiposity measures and resistin 
levels. This is consistent with most previous studies that found no correlations between 
markers of adiposity and resistin  [16, 17, 29, 58–63] , whereas other studies reported a 
positive relation of obesity to resistin levels  [15, 41, 42, 64–66] . Only one population-based 
study that examined the relation of VAT and SAT to resistin reported results from multi-
variate analyses and found similar relations of VAT and SAT to resistin in women and no asso-
ciation between VAT and resistin in men  [42] . We found that the relation between SAT and 
resistin was stronger than the relation of other measures of obesity to resistin. However, 
resistin is not expressed by adipocytes but is secreted by macrophages located within adipose 
tissue depots  [67] . Hence, circulating resistin is not directly related to adiposity levels but to 
the degree of inflammation within the adipose tissue depots  [9] . 
 Largely similar to our results, previous studies reported that VAT, SAT, BMI, or WC were 
inversely associated with adiponectin  [35, 40, 43, 44, 68] . In our study, the inverse relation 
of VAT to adiponectin was attenuated and rendered non-significant after mutual adjustment 
for other parameters of systemic chronic inflammation and when SAT was included in the 
model. We found that BMI was a stable indicator of decreased adiponectin levels, showing an 
inverse association in the overall population before and after adjustment for other variables 
and across a number of stratified analyses. In addition, we found that the relation of BMI to 
adiponectin was stronger than the relation to other markers of adiposity in all analyses. This 
suggests that adiponectin may represent metabolic processes that are associated with BMI 
better than those related to VAT or SAT.
 The major strength of our study is that, to the best of our knowledge, it represents the 
first study to examine associations between several different body fat measures and numerous 
selected parameters of chronic inflammation in healthy adults. A further asset of our study is 
that we accounted for correlations between individual parameters of systemic inflammation 
by mutual adjustment in our multivariate models, which has not been undertaken in any 
previous study. In addition, we conducted numerous informative exploratory subgroup 
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analyses. Ultrasound is a less sophisticated method to measure VAT and SAT compared to the 
gold standard methods of magnetic resonance imaging (MRI) or computer tomography (CT). 
However, MRI and CT approaches are limited in field conditions due to their associated costs 
and issues regarding accessibility, contraindications, and in terms of CT examinations, 
potential adverse effects of radiation.  We have recently reported that ultrasound represents 
a suitable technique to validly and reproducibly assess VAT and SAT in population-based 
research settings  [45] . Our blood samples were non-fasting, but we focused on parameters 
that are unaffected by fasting status  [69, 70] .
 Limitations of our study include the small sample size, potentially resulting in insufficient 
statistical power to detect relations, particularly in stratified analyses. Due to the numerous 
additional analyses performed, some of our findings may have been the result of multiple 
testing. In addition, the cross-sectional nature of our study design precludes an assessment 
of cause-effect relationships. Because analyses were based on a single laboratory measurement, 
they may not represent true long-term average serum concentrations of parameters of 
chronic inflammation. 
 In conclusion, we found that VAT, SAT, BMI, and WC showed distinct associations with 
selected parameters of chronic inflammation. Our study suggests that each of the anthropo-
metric variables provides distinct information regarding metabolic processes related to 
inflammatory parameters. Compared to VAT, BMI, and WC, SAT was the strongest indicator 
for increased hs-CRP concentrations. BMI was the strongest indicator for decreased adipo-
nectin levels. Albeit not significant, VAT was the strongest indicator for increased levels of 
IL-6 and TNF-α. WC represented a less consistent indicator when examining relations to 
inflammatory parameters. Subgroup analyses showed that gender, BMI, current smoking, 
and use of aspirin or NSAIDs modify the relations of adiposity measures to the levels of inflam-
mation parameters. The distinct relations of VAT, SAT, BMI, and WC to selected parameters 
of systemic chronic inflammation emphasize the importance of accurately differentiating 
between body fat compartments when evaluating the role of adiposity-associated systemic 
chronic inflammation in the development of metabolic diseases. 
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